| Symbol |
Company |
Application # |
Date |
Title |
| LLY | Eli Lilly & | 20110046143 | 20110224 | Disubstituted phthalazine hedgehog pathway antagonists |
| LLY | Eli Lilly & | 20110039855 | 20110217 | Tetrahydrocyclopenta[b]indole androgen receptor modulators |
| LLY | Eli Lilly & | 20110034484 | 20110210 | 1,5-diphenyl-pyrrolidin-2-one compounds as cb-1 ligands |
| LLY | Eli Lilly & | 20110034373 | 20110210 | Use of an fgf-21 compound and a glp-1 compound for the treatment of obesity |
| LLY | Eli Lilly & | 20110027261 | 20110203 | Anti-hepcidin antibodies and uses thereof |
| LLY | Eli Lilly & | 20110027290 | 20110203 | Anti-il-17 antibodies |
| LLY | Eli Lilly & | 20110028520 | 20110203 | 1,5-diphenyl-pyrrolidin-2-one compounds as cb-1 ligands |
| LLY | Eli Lilly & | 20110015199 | 20110120 | Gpr119 agonists |
| LLY | Eli Lilly & | 20110009458 | 20110113 | Stable formulations of thiadiazole derivative |
| LLY | Eli Lilly & | 20110009395 | 20110113 | Bace inhibitors |
| LLY | Eli Lilly & | 20110008355 | 20110113 | Anti-flt3 antibodies |
| LLY | Eli Lilly & | 20100331309 | 20101230 | Trans-4-[[(5s)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl](2-methyl-2h-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1h-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid |
| LLY | Eli Lilly & | 20100324140 | 20101223 | Glucagon receptor antagonists, preparation and therapeutic uses |
| LLY | Eli Lilly & | 20100324129 | 20101223 | Ectoparasiticidal methods and formulations |
| LLY | Eli Lilly & | 20100324048 | 20101223 | Disubstituted phthalazine hedgehog pathway antagonists |
| LLY | Eli Lilly & | 20100305128 | 20101202 | Pyrimidinyl-thiophene kinase modulators |
| LLY | Eli Lilly & | 20100286209 | 20101111 | Vinyl indazolyl compounds |
| LLY | Eli Lilly & | 20100286139 | 20101111 | Amino pyrazole compound |
| LLY | Eli Lilly & | 20100286076 | 20101111 | Ectoparasiticidal methods and formulations |
| LLY | Eli Lilly & | 20100285005 | 20101111 | Anti-cxcr4 antibodies |
| LLY | Eli Lilly & | 20100280062 | 20101104 | (e)-n--methanesulfonamide as glucocorticoid receptor modulator for the treatment of rheumatoid arthritis |
| LLY | Eli Lilly & | 20100272735 | 20101028 | Method to treat using antagonistic anti-htnfsf13b human antibodies |
| LLY | Eli Lilly & | 20100268474 | 20101021 | Methods, systems and computer program products for predicting responsiveness to a pharmaceutical therapy for obesity or evaluating investigational pharmaceutical agents |
| LLY | Eli Lilly & | 20100260766 | 20101014 | Stable antibody formulations |
| LLY | Eli Lilly & | 20100260754 | 20101014 | Dkk-1 antibodies |
| LLY | Eli Lilly & | 20100261762 | 20101014 | Serotonin and norepinephrine reuptake inhibitor |
| LLY | Eli Lilly & | 20100261712 | 20101014 | Hematopoietic neoplasm chemotherapy |
| LLY | Eli Lilly & | 20100255106 | 20101007 | Benzothiophenes, formulations containing same, and methods |
| LLY | Eli Lilly & | 20100249075 | 20100930 | Substituted tetralins as selective estrogen receptor-beta agonists |
| LLY | Eli Lilly & | 20100248375 | 20100930 | Method for predicting responsiveness to a pharmaceutical therapy for obesity |
| LLY | Eli Lilly & | 20100221263 | 20100902 | Anti-sclerostin antibodies |
| LLY | Eli Lilly & | 20100221267 | 20100902 | Pdgfr beta-specific inhibitors |
| LLY | Eli Lilly & | 20100222339 | 20100902 | Thiazole pyrazolopyrimidines crf1 receptor antagonists |
| LLY | Eli Lilly & | 20100210583 | 20100819 | Novel antifolate combination therapies |
| LLY | Eli Lilly & | 20100204207 | 20100812 | Compounds and methods for treating dyslipidemia |
| LLY | Eli Lilly & | 20100197620 | 20100805 | Pesticidal formulations |
| LLY | Eli Lilly & | 20100196405 | 20100805 | Glp-1 fc fusion protein formulation |
| LLY | Eli Lilly & | 20100197660 | 20100805 | Azepine derivatives as gamma-secretase inhibitors |
| LLY | Eli Lilly & | 20100197669 | 20100805 | Kappa selective opioid receptor antagonist |
| LLY | Eli Lilly & | 20100197700 | 20100805 | 5-ht7 receptor antagonists |
| LLY | Eli Lilly & | 20100184764 | 20100722 | Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| LLY | Eli Lilly & | 20100179190 | 20100715 | Bicyclic pyrazolo protein kinase modulators |
| LLY | Eli Lilly & | 20100179184 | 20100715 | Article of manufacture for prasugrel |
| LLY | Eli Lilly & | 20100173857 | 20100708 | Spinosyns for wound healing |
| LLY | Eli Lilly & | 20100166755 | 20100701 | Anti-egfr antibodies |
| LLY | Eli Lilly & | 20100166764 | 20100701 | Anti-myostatin antibodies |
| LLY | Eli Lilly & | 20100166884 | 20100701 | Potentiation of cancer chemotherapy by 7-(2, 5- dihydro- 4-imidazo [1, 2-a] pyridine-3-yl-2,5-dioxo-ih-pyrrol-3-yl)-9-fluoro-1,2,3,4 tetrahydro -2-(1-piperidinyl-carbonyl)-pyrrolo [3,2,1-jk] [1,4] benzodiazepine |
| LLY | Eli Lilly & | 20100160406 | 20100624 | Histamine h3 receptor agents, preparation and therapeutic uses |
| LLY | Eli Lilly & | 20100160395 | 20100624 | Cyclopropyl compounds |
| LLY | Eli Lilly & | 20100160340 | 20100624 | Protein kinase inhibitors |
| LLY | Eli Lilly & | 20100160319 | 20100624 | Histamine h3 receptor agents, preparation and therapeutic uses |
| LLY | Eli Lilly & | 20100160288 | 20100624 | Purine compounds |
| LLY | Eli Lilly & | 20100158920 | 20100624 | Fully human antibodies directed against the human insulin-like growth factor-1 receptor |
| LLY | Eli Lilly & | 20100152660 | 20100617 | Cartridge with multiple injection needles for a medication injection device |
| LLY | Eli Lilly & | 20100152181 | 20100617 | Amino pyrazole compound |
| LLY | Eli Lilly & | 20100152166 | 20100617 | Compounds and methods for modulating fxr |
| LLY | Eli Lilly & | 20100136021 | 20100603 | Tgf-beta binding antibodies |
| LLY | Eli Lilly & | 20100137417 | 20100603 | Glucagon receptor antagonists, preparation and therapeutic uses |
| LLY | Eli Lilly & | 20100137602 | 20100603 | Process and intermediates for preparing arzoxifene |
| LLY | Eli Lilly & | 20100130466 | 20100527 | Triazolyl aminopyrimidine compounds |
| LLY | Eli Lilly & | 20100130409 | 20100527 | Cyclic peptide cxcr4 antagonists |
| LLY | Eli Lilly & | 20100129369 | 20100527 | C-met antibodies |
| LLY | Eli Lilly & | 20100119516 | 20100513 | Anti-tgf-beta receptor ii antibodies |
| LLY | Eli Lilly & | 20100120739 | 20100513 | Triazolopyridazine protein kinase modulators |
| LLY | Eli Lilly & | 20100120785 | 20100513 | 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines and pyridines and 3-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-2-phenyl pyridines as 5-ht7 receptor antagonists |
| LLY | Eli Lilly & | 20100120854 | 20100513 | Tgf-beta inhibitors |
| LLY | Eli Lilly & | 20100120801 | 20100513 | Akt and p70 s6 kinase inhibitors |
| LLY | Eli Lilly & | 20100113579 | 20100506 | Prodrugs of excitatory amino acids |
| LLY | Eli Lilly & | 20100106098 | 20100429 | Medication injector apparatus with drive assembly that facilitates reset |
| LLY | Eli Lilly & | 20100105683 | 20100429 | Compounds useful for inhibiting chk1 |
| LLY | Eli Lilly & | 20100098696 | 20100422 | Fibroblast growth factor receptor-3 (fgfr-3) inhibitors and methods of treatment |
| LLY | Eli Lilly & | 20100099725 | 20100422 | Peroxisome proliferator activated receptor modulators |
| LLY | Eli Lilly & | 20100094014 | 20100415 | Excitatory amino acid receptor antagonists |
| LLY | Eli Lilly & | 20100087631 | 20100408 | Anti-myostatin antibodies |
| LLY | Eli Lilly & | 20100087431 | 20100408 | Triazolyl aminopyrimidine compounds |
| LLY | Eli Lilly & | 20100087368 | 20100408 | Treating acute renal failure with soluble thrombomodulin variants |
| LLY | Eli Lilly & | 20100080811 | 20100401 | Anti-myostatin antibodies |
| LLY | Eli Lilly & | 20100081641 | 20100401 | Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer |
| LLY | Eli Lilly & | 20100076065 | 20100325 | Vitamin d receptor modulators |
| LLY | Eli Lilly & | 20100076001 | 20100325 | Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer |
| LLY | Eli Lilly & | 20100075976 | 20100325 | Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists |
| LLY | Eli Lilly & | 20100069425 | 20100318 | Glucocorticoid receptor modulator and methods of use |
| LLY | Eli Lilly & | 20100069404 | 20100318 | Tetrahydrocyclopenta[b] indole compounds as androgen receptor modulators |
| LLY | Eli Lilly & | 20100069352 | 20100318 | 5- [4-(azetidin-3-yloxy)-phenyl]-2-phenyl-5h-thiazolo[5,4-c] pyridin-4-one derivatives and their use as mch receptor antagonists |
| LLY | Eli Lilly & | 20100056795 | 20100304 | Novel intermediate and process useful in the preparation of -(2-chlorophenyl)-methanone |
| LLY | Eli Lilly & | 20100048460 | 20100225 | Selective vpac2 receptor peptide agonists |
| LLY | Eli Lilly & | 20100048580 | 20100225 | Histamine h3 receptor agents, preparation and therapeutic uses |
| LLY | Eli Lilly & | 20100049125 | 20100225 | Delay mechanism for automatic injection device |
| LLY | Eli Lilly & | 20100040633 | 20100218 | Binding compositions: related reagents |
| LLY | Eli Lilly & | 20100029608 | 20100204 | Histamine h3 receptor agents, preparation and therapeutic uses |
| LLY | Eli Lilly & | 20100028347 | 20100204 | Antibodies against vascular endothelial growth factor receptor-1 |
| LLY | Eli Lilly & | 20100028342 | 20100204 | Insulin-like growth factor-1 receptor antagonists for modulation of weight and liposity |
| LLY | Eli Lilly & | 20100022529 | 20100128 | Amidophenoxyindazoles useful as inhibitors of c-met |
| LLY | Eli Lilly & | 20100022550 | 20100128 | Tetrahydrocarbazole derivatives useful as androgen receptor modulators |
| LLY | Eli Lilly & | 20100022560 | 20100128 | Thiophene pyrazolopyrimidine compounds |
| LLY | Eli Lilly & | 20100022512 | 20100128 | Compositions of chk1 inhibitors and cyclodextrin |
| LLY | Eli Lilly & | 20100016375 | 20100121 | 1,5-diphenyl-3-pyridinylamino-1,5-dihydropyrrolidin-2-one as cb1 receptor modulator |
| LLY | Eli Lilly & | 20100016373 | 20100121 | Imidazole carboxamides |
| LLY | Eli Lilly & | 20100016350 | 20100121 | Novel mch receptor antagonists |
| LLY | Eli Lilly & | 20100015155 | 20100121 | Pegylated abeta fab |
| LLY | Eli Lilly & | 20100010090 | 20100114 | Ampa receptor potentiators |
| LLY | Eli Lilly & | 20100009916 | 20100114 | Selective vpac2 receptor peptide agonists |
